Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma

BACKGROUND & AIMS: Sorafenib is a multireceptor tyrosine kinase inhibitor that can prolong overall survival in patients with advanced hepatocellular carcinoma (HCC). Although most HCC patients who receive sorafenib ultimately show disease progression, it still is unclear whether and how HCC cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Mol Gastroenterol Hepatol
Main Authors: Hashiba, Tomomi, Yamashita, Taro, Okada, Hikari, Nio, Kouki, Hayashi, Takehiro, Asahina, Yoshiro, Hayashi, Tomoyuki, Terashima, Takeshi, Iida, Noriho, Takatori, Hajime, Shimakami, Tetsuro, Kawaguchi, Kazunori, Arai, Kuniaki, Sakai, Yoshio, Yamashita, Tatsuya, Mizukoshi, Eishiro, Takamura, Hiroyuki, Ohta, Tetsuo, Honda, Masao, Kaneko, Shuichi
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305345/
https://ncbi.nlm.nih.gov/pubmed/32169577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2020.02.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados